• C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from Brokerages

    Source: Buzz FX / 14 Jan 2025 04:15:17   America/Chicago


    C4 Therapeutics, Inc. (NASDAQ:CCCC) Receives Consensus Rating of "Moderate Buy" from Brokerages Written by MarketBeat January 14, 2025 Share Link copied to clipboard. Shares of C4 Therapeutics, Inc. ( NASDAQ:CCCC - Get Free Report ) have be
    Read more...
Share on,